JBS offers diversified protein exposure and a visible North American beef recovery, but leverage and earnings volatility keep the stock at Hold. The shares look inexpensive on forward earnings, yet the report still sees enough risk to justify a discount to fair value.
JBS N.V. (JBS) is a global protein platform trading at $13.12 per share as of November 9, 2026. The investment case rests on scale, geographic diversification, a broad mix of beef, pork, poultry and prepared foods, and a potential recovery in North American beef profitability. The counterweight is leverage, weak recent earnings quality and exposure to livestock costs, trade policy and food-sector regulation.
The latest quarter was mixed. Third-quarter 2026 revenue reached $22.7B, up 1.0% from $22.6B a year earlier, while attributable EPS fell to $0.15 from $0.52. Management reported that North American beef margins improved from negative 2.9% in July to breakeven in August and positive 3.9% in September. That progression gives the recovery case a concrete operating marker, but the quarter still showed how quickly earnings can weaken when protein spreads compress.
JBS suits a moderate-risk investor who can tolerate commodity cycles and wants exposure to a large food producer rather than a high-margin branded consumer company. The shares trade at 11.7 times trailing earnings and 3.9 times forward earnings on the supplied valuation data. Those multiples are inexpensive if the analyst EPS path from $3.67 in 2026 to $10.57 in 2028 is achieved, but the 2-of-5 recent earnings beat rate argues against treating that path as automatic.
The central judgment is Hold. The recovery potential is real, particularly in North American beef and prepared foods, but the balance sheet and earnings volatility justify a discount to the $17.25 analyst target. The report's fair value estimate is $16.00 per share.
JBS N.V. is headquartered in Amstelveen, the Netherlands, and trades on the NYSE under JBS. The company was founded in 1953 and completed its dual listing on the NYSE and B3 in June 2025. The 20-F filed on March 25, 2026 states that JBS N.V. became the holding entity for JBS S.A. and its consolidated subsidiaries after the corporate restructuring.
The business processes and sells beef, pork, poultry, lamb, fish, plant-based products, cultured protein and prepared foods. It also operates in leather, collagen, biodiesel, natural casings, metal packaging, transportation, waste management and recycling. JBS says it operates in 25 countries across five continents, with more than 250 production facilities and commercial offices, approximately 280,000 employees and more than 320,000 customers in over 180 countries.
The portfolio includes Seara, Doriana, Pilgrim's, Moy Park, Primo, Friboi, Maturatta, Swift, Ozo and other brands. JBS also owns approximately 82% of Pilgrim's Pride Corporation, giving the group a substantial position in poultry and prepared foods alongside its direct beef, pork and lamb operations.
The corporate structure brings scale but also adds complexity. JBS operates across multiple currencies, legal systems and livestock markets, while its dual-class share structure concentrates voting power with Class B shareholders. The 20-F identifies shareholder control, exports, animal disease, food safety, debt and emerging-market exposure as material risks.
JBS does not depend on one protein cycle. Its operating portfolio spans beef in Brazil, North America and Australia, poultry through Pilgrim's and Seara, pork in North America and Brazil, and prepared foods across several regions. Management described Australia as benefiting from robust global beef demand and attractive export opportunities in the second quarter of 2026.
JBS Brazil was a strong contributor in the second quarter. Management reported $4.6B of net revenue, adjusted EBITDA of $273M and a 5.9% margin in the business context, despite a 12% increase in cattle prices. The company used its export and domestic channels to direct volumes toward markets offering stronger returns, with China remaining an important destination.
North American beef remains the most important recovery segment. Its second-quarter 2026 EBITDA margin improved to negative 1.3% from negative 3.9% a year earlier. In the third quarter, monthly margins improved from negative 2.9% in July to breakeven in August and positive 3.9% in September. The sequence points to operational improvement before a full cattle-cycle recovery.
Pork and poultry provide useful diversification. JBS reported a second-quarter pork EBITDA margin of 8.9%, up from 6.5% a year earlier. Pilgrim's demand remained healthy across retail and foodservice, although supply expanded faster than demand. That combination shows the value of diversification, while also showing that each protein division carries its own supply and pricing equation.
Get AI research on any stock
Instant reports, daily intelligence, and an AI analyst in your pocket.
JBS's flagship product is best understood as a branded protein system rather than one individual item. Friboi and Maturatta anchor Brazilian beef, Swift extends the prepared and packaged meat offering, Seara covers poultry, pork and processed foods, and Pilgrim's provides a major poultry platform in the United States and other markets.
The strategic shift is toward value-added products. Management said North American beef initiatives focus on selling more ground beef and other value-added items, rather than relying only on yield improvements. The decision to operate the Sodertorn facility as a value-added plant instead of closing it was presented as evidence of demand for these products.
Prepared foods continued to grow sales and margins in the second quarter, led by Just Bare according to the supplied forecast context. JBS also identifies itself as a leading prepared-foods company in Australia, New Zealand, the United Kingdom, Brazil, Mexico and the United States. This mix matters because prepared foods can create more room for branding, convenience and product differentiation than unprocessed commodity meat.
The product economics remain cyclical. The 20-F states that raw materials represented a majority of total product cost in 2025 and that JBS generally does not use long-term fixed-price sales arrangements with customers. A stronger brand mix can reduce commodity exposure, but it does not remove the effect of cattle, hog, poultry, corn and soymeal prices.
JBS's competitive advantage is primarily a scale-and-operations advantage. Its presence in 25 countries, more than 250 facilities and over 180 customer markets allows the company to route protein across regions and channels. Management specifically described the ability to allocate production toward markets where JBS creates the most value.
Vertical integration increases the value captured from each animal. JBS operates businesses in leather, collagen, biodiesel, natural casings and packaging, which gives the company outlets for byproducts and supporting materials. These businesses do not convert JBS into a high-margin consumer company, but they can improve plant utilization and reduce waste.
The North American beef integration is a direct operating initiative. Management combined two previously separate business units because market conditions had changed, citing complementary strengths and sales synergies. Executives described a 3% improvement plan that was still at an early stage in the second quarter.
JBS also secured a strategic partnership involving a $2.5B equity investment for a 25% stake in its Australia and New Zealand operations. Management said the partnership could provide access to up to $5B for acquisitions, projects and growth opportunities in Indonesia and Southeast Asia while keeping the operations fully consolidated. That structure supports expansion, but it also places capital allocation discipline at the center of the investment case.
JBS's supply chain begins with independently sourced livestock and feed inputs and ends in retail, foodservice and export markets. The 20-F identifies livestock and animal feed prices as major drivers of operating margins. JBS also faces disease, weather, trade, labor and environmental risks across its production footprint.
Export exposure is meaningful. Exports represented 26% of 2025 net revenue according to the supplied business context. In the second quarter, higher receivable discounts and advance payments from Chinese customers helped working capital, while higher cattle prices and slaughter volumes increased accounts payable.
The North American cattle supply chain has a specific recovery path. Management said the reopening of three Mexican ports could restore much of the historical cattle flow into the United States. Executives estimated that the Douglas port could handle 300,000 to 400,000 head and said the three ports together could handle a substantial portion of normalized flow.
Capital intensity remains material. JBS reported 2025 operating cash flow of $15.5B, capital expenditures of $11.4B and free cash flow of $4.1B. Second-quarter 2026 free cash flow was $239.6M, with capital expenditures of $612.5M. Management's 2026 cash-flow framework used $2.0B of capital expenditures and a $5.1B EBITDA breakeven exercise.
JBS operates inside a large packaged-food and protein market. The global packaged-food market was estimated at $6.61T in 2026 and projected to reach $8.15T by 2031, a 4.3% compound annual growth rate. The processed-meat market was estimated at $170.9B in 2025 and projected to reach $190.8B by 2030, a 2.2% compound annual growth rate.
Protein demand is shifting by species and channel. OECD-FAO reported that global meat production increased 1.4% in 2025 to 375 million tonnes, with poultry as the main growth driver. Beef production declined because of herd reductions in major producing countries, especially the United States.
Poultry has a structural cost advantage because it converts feed into human food more efficiently than larger livestock, according to USDA material in the supplied research. USDA also projected higher broiler production and exports in 2026 and 2027. JBS's poultry exposure through Pilgrim's and Seara positions the company in that faster-growing protein category.
Convenience and health claims support the prepared-foods opportunity. Market research identifies high-protein, fortified, clean-label and ready-to-eat products as important packaged-food trends. JBS's expansion into prepared meals, protein-forward products and value-added meats aligns with those trends, although market growth alone does not guarantee margin expansion.
Like what you're reading?
Get full access to AI-powered research reports, market analysis, and portfolio tools.
JBS serves a broad customer base of more than 320,000 customers in over 180 countries. The mix includes retailers, foodservice operators, distributors and industrial food customers. This reach reduces dependence on one account, but the 20-F also identifies customer consolidation as a competitive risk.
The channel mix is changing. Management said United States consumers were shifting protein consumption toward retail and eating at home rather than away-from-home foodservice. That shift supports packaged products and branded offerings, while it creates pressure for foodservice-heavy categories.
China remains an important customer market for Brazilian beef. JBS reported that lower exports to China after completion of the 2026 quota hurt Brazil in the third quarter, while Chinese demand strengthened at the start of the fourth quarter as the market positioned for the 2027 quota. The episode shows both the value and risk of export access.
Consumer demand has held up better in beef and poultry than in some pork categories. In the second-quarter call, management described beef demand as strong and said protein categories had shown less substitution than previously expected. That supports volume resilience, although price-sensitive consumers can still change channels and product mix.
JBS competes with different companies by protein and geography. Tyson Foods is the closest diversified United States peer across beef, chicken, pork and prepared foods. WH Group and Smithfield are major pork competitors, while Marfrig and Minerva Foods are important beef competitors in Brazil and South America.
Prepared foods add another competitive group that includes Hormel Foods, Conagra and Kraft Heinz. These companies compete more directly for branded and convenience-food spending than for livestock procurement. JBS's advantage is the combination of primary processing scale and downstream brands.
Scale supports purchasing, distribution and market access, but it does not guarantee superior returns. The 20-F describes the industry as competitive and states that raw-material prices and product selling prices can change sharply. A large processor can spread fixed costs across more facilities, yet it remains exposed to the same cattle, hog, poultry and feed cycles as its peers.
JBS's strongest competitive proof point is operational recovery. North American beef moved from a negative 3.9% EBITDA margin in the second quarter of 2025 to negative 1.3% in the second quarter of 2026, followed by positive monthly margins in September. The improvement supports the case that integration and commercial execution can matter even before cattle supplies fully normalize.
JBS is sensitive to inflation, interest rates, currencies, trade restrictions and economic conditions in Brazil, the United States, Australia, China and other operating markets. The 20-F specifically identifies exchange-rate fluctuations, political risk, trade barriers, exchange controls and economic deterioration as risks to financial results.
Geopolitical events can affect both costs and market access. The 20-F cites the Russia-Ukraine war and Middle East conflict as risks that can raise food, ingredient and energy prices and disrupt trade and supply chains. JBS also faces country-specific sanitary restrictions, including those linked to animal disease outbreaks.
The North American cattle cycle is the most important near-term macro factor for beef margins. Tight cattle supplies and historically high cattle costs pressured North American beef in 2026. Management linked the prospective improvement to Mexican cattle flows, early herd-rebuilding signals and a gradual return toward healthier supply and demand.
Brazil adds a second macro layer through currency and export demand. JBS Brazil benefited from export demand in the second quarter, while lower China exports affected the third quarter after the quota was completed. A stronger domestic consumption period in Brazil and better Chinese demand entering the fourth quarter support the operating case, but both depend on market conditions outside JBS's direct control.
JBS carries a C+ balance sheet grade, with leverage and debt highlighted as key risks alongside its global operating complexity.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →Third-quarter 2026 revenue rose just 1.0% to $22.7B while attributable EPS fell from $0.52 to $0.15, underscoring how quickly margins can compress.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →Analysts still see EPS climbing from $3.67 in 2026 to $10.57 in 2028, but the report notes only a 2-of-5 recent earnings beat rate.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →JBS trades at 11.7x trailing earnings and 3.9x forward earnings, a cheap multiple if the projected profit rebound materializes.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →The stock’s $17.25 analyst target sits above the $16 fair value, but the report keeps the recommendation at Hold because the recovery is not yet fully proven.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →JBS combines global scale, multi-protein diversification and a credible operating recovery plan. The clearest evidence is the improvement in North American beef margins from negative 2.9% in July to positive 3.9% in September 2026, alongside the 8.9% second-quarter pork margin and the prepared-foods expansion.
The financial profile is less settled. Third-quarter EPS fell to $0.15 from $0.52, leverage reached 3.54 times, and recent earnings beats occurred in only 2 of 5 reported periods. JBS can create substantial value if operating recovery converts into durable cash flow, but the balance sheet makes execution more important than the low headline multiple suggests.
At $13.12, the shares offer upside to the report's $16.00 fair-value estimate, but the risk-reward profile is balanced rather than one-sided. A Hold is appropriate for a medium-term investor who values the recovery potential but does not want to pay ahead of consistent earnings delivery.
Get AI-powered research reports, daily market intelligence, and a personal analyst in your pocket.
Get Full Access →Not ready to subscribe? ·
Cancel anytime
Jbs N.V. (JBS) rose despite a sharp 3Q26 earnings miss, as investors looked past weaker EPS, EBITDA and free cash flow to segment trends and management’s 2026 cash flow targets. This deep-dive examines margin pressure, leverage, U.S. Beef recovery and what the results mean for the stock.
Jbs N.V. (JBS) slips 1.6% after reporting earnings misses, with investors reacting to weaker-than-expected results and renewed pressure on the stock.
Revolution Medicines has crossed into commercial oncology with a strong RASONQUE launch, but heavy losses and a rich valuation keep the stock at Hold. The pipeline and clinical data support the long-term story, yet near-term upside looks balanced against execution risk.